Add to ORKG© 2015 Sundell et al.Background: Anti-malarial chemoprevention with dihydroartemisinin-piperaquine (DHA/PQ) is a promising tool for malaria control, but its efficacy in children may be limited by inadequate drug exposure. Methods: Children were enrolled i
Background. Intermittent preventive treatment (IPT) in schoolchildren offers a promising option for ...
Chemoprevention offers a promising strategy for prevention of malaria in African children. However, ...
BACKGROUND: Results from trials of intermittent preventive treatment (IPT) in infants and children h...
Background: Anti-malarial chemoprevention with dihydroartemisinin-piperaquine (DHA/PQ) is a promisin...
Intermittent preventive treatment (IPT) with dihydroartemisinin-piperaquine (DP) is highly protectiv...
BACKGROUND: Although dihydroartemisinin-piperaquine (DP) is used primarily in children, pharmacokine...
BackgroundAlthough dihydroartemisinin-piperaquine (DP) is used primarily in children, pharmacokineti...
Background: Treatment for severe malaria must be prompt with effective parenteral antimalarial drugs...
BACKGROUND: The long terminal half life of piperaquine makes it suitable for intermittent preventive...
Background: One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-p...
Young children are the population most severely affected by Plasmodium falciparum malaria. Seasonal ...
BACKGROUND:The combination of short-acting dihydroartemisinin and long-acting piperaquine (DP) is am...
Background One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-pi...
Young children are the population most severely affected by Plasmodium falciparum malaria. Seasonal ...
The long terminal half life of piperaquine makes it suitable for intermittent preventive treatment f...
Background. Intermittent preventive treatment (IPT) in schoolchildren offers a promising option for ...
Chemoprevention offers a promising strategy for prevention of malaria in African children. However, ...
BACKGROUND: Results from trials of intermittent preventive treatment (IPT) in infants and children h...
Background: Anti-malarial chemoprevention with dihydroartemisinin-piperaquine (DHA/PQ) is a promisin...
Intermittent preventive treatment (IPT) with dihydroartemisinin-piperaquine (DP) is highly protectiv...
BACKGROUND: Although dihydroartemisinin-piperaquine (DP) is used primarily in children, pharmacokine...
BackgroundAlthough dihydroartemisinin-piperaquine (DP) is used primarily in children, pharmacokineti...
Background: Treatment for severe malaria must be prompt with effective parenteral antimalarial drugs...
BACKGROUND: The long terminal half life of piperaquine makes it suitable for intermittent preventive...
Background: One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-p...
Young children are the population most severely affected by Plasmodium falciparum malaria. Seasonal ...
BACKGROUND:The combination of short-acting dihydroartemisinin and long-acting piperaquine (DP) is am...
Background One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-pi...
Young children are the population most severely affected by Plasmodium falciparum malaria. Seasonal ...
The long terminal half life of piperaquine makes it suitable for intermittent preventive treatment f...
Background. Intermittent preventive treatment (IPT) in schoolchildren offers a promising option for ...
Chemoprevention offers a promising strategy for prevention of malaria in African children. However, ...
BACKGROUND: Results from trials of intermittent preventive treatment (IPT) in infants and children h...